Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer


Ayesha Murtuza
Feb 15, 2019; 79:689-698
Articles

Powered by WPeMatico

Leave a Reply